Stock Track | BioLife Solutions Soars 6.51% After-Hours on Strong Q4 Earnings Beat and Upbeat 2026 Guidance

Stock Track

Feb 27

BioLife Solutions Inc. (BLFS) saw its stock price surge 6.51% in after-hours trading on Thursday, following the release of its fourth-quarter and full-year 2025 financial results that significantly exceeded analyst expectations.

The cell processing tools company reported quarterly earnings of $0.04 per share, beating the consensus estimate of a $0.02 loss by a wide margin. Revenue for the quarter reached $24.8 million, a 20% year-over-year increase and above the $24.1 million forecast. For the full year, revenue grew 29% to $96.2 million. Management also provided strong guidance for 2026, projecting revenue between $112.5 million and $115.0 million, representing growth of 17% to 20% over 2025, and anticipating full-year GAAP profitability.

The positive results were driven by sustained strength in the company's biopreservation media franchise, which holds a dominant market share in commercially sponsored cell and gene therapy clinical trials. CEO Roderick de Greef highlighted the company's streamlined operations and the expanding CGT end market as key drivers for future growth and operating leverage.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1152554436"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1152554436\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1152554436?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 06:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152554436","market":"sg","top_or_hot":-1,"title":"Stock Track | BioLife Solutions Soars 6.51% After-Hours on Strong Q4 Earnings Beat and Upbeat 2026 Guidance","media":"Stock Track","content":"<p>BioLife Solutions Inc. (BLFS) saw its stock price surge 6.51% in after-hours trading on Thursday, following the release of its fourth-quarter and full-year 2025 financial results that significantly exceeded analyst expectations.</p><p>The cell processing tools company reported quarterly earnings of $0.04 per share, beating the consensus estimate of a $0.02 loss by a wide margin. Revenue for the quarter reached $24.8 million, a 20% year-over-year increase and above the $24.1 million forecast. For the full year, revenue grew 29% to $96.2 million. Management also provided strong guidance for 2026, projecting revenue between $112.5 million and $115.0 million, representing growth of 17% to 20% over 2025, and anticipating full-year GAAP profitability.</p><p>The positive results were driven by sustained strength in the company's biopreservation media franchise, which holds a dominant market share in commercially sponsored cell and gene therapy clinical trials. CEO Roderick de Greef highlighted the company's streamlined operations and the expanding CGT end market as key drivers for future growth and operating leverage.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BioLife Solutions Soars 6.51% After-Hours on Strong Q4 Earnings Beat and Upbeat 2026 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BioLife Solutions Soars 6.51% After-Hours on Strong Q4 Earnings Beat and Upbeat 2026 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-27 06:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioLife Solutions Inc. (BLFS) saw its stock price surge 6.51% in after-hours trading on Thursday, following the release of its fourth-quarter and full-year 2025 financial results that significantly exceeded analyst expectations.</p><p>The cell processing tools company reported quarterly earnings of $0.04 per share, beating the consensus estimate of a $0.02 loss by a wide margin. Revenue for the quarter reached $24.8 million, a 20% year-over-year increase and above the $24.1 million forecast. For the full year, revenue grew 29% to $96.2 million. Management also provided strong guidance for 2026, projecting revenue between $112.5 million and $115.0 million, representing growth of 17% to 20% over 2025, and anticipating full-year GAAP profitability.</p><p>The positive results were driven by sustained strength in the company's biopreservation media franchise, which holds a dominant market share in commercially sponsored cell and gene therapy clinical trials. CEO Roderick de Greef highlighted the company's streamlined operations and the expanding CGT end market as key drivers for future growth and operating leverage.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BLFS","symbol_name":"BioLife Solutions Inc.","start_time":0,"source_url":"","article_id":"1152554436","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152554436","pubTimestamp":1772145172,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BioLife Solutions Inc. (BLFS) saw its stock price surge 6.51% in after-hours trading on Thursday, following the release of its fourth-quarter and full-year 2025 financial results that significantly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BLFS":"BioLife Solutions Inc."},"translate_title":"股票追踪|BioLife Solutions盘后飙升6.51%，第四季度盈利强劲，2026年指引乐观","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLFS":1},"content_text":"BioLife Solutions Inc. (BLFS) saw its stock price surge 6.51% in after-hours trading on Thursday, following the release of its fourth-quarter and full-year 2025 financial results that significantly exceeded analyst expectations.The cell processing tools company reported quarterly earnings of $0.04 per share, beating the consensus estimate of a $0.02 loss by a wide margin. Revenue for the quarter reached $24.8 million, a 20% year-over-year increase and above the $24.1 million forecast. For the full year, revenue grew 29% to $96.2 million. Management also provided strong guidance for 2026, projecting revenue between $112.5 million and $115.0 million, representing growth of 17% to 20% over 2025, and anticipating full-year GAAP profitability.The positive results were driven by sustained strength in the company's biopreservation media franchise, which holds a dominant market share in commercially sponsored cell and gene therapy clinical trials. CEO Roderick de Greef highlighted the company's streamlined operations and the expanding CGT end market as key drivers for future growth and operating leverage.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}